首页> 外文期刊>BMC Health Services Research >Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial)
【24h】

Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial)

机译:从初级保健中远程监测患有心力衰竭或慢性肺病的家庭护理患者对医疗资源使用的影响(TELBIL研究随机对照试验)

获取原文
           

摘要

Background There is growing evidence that home telemonitoring can be advantageous in societies with increasing prevalence of chronic diseases. The main objective of this study is to evaluate the effect of a primary care-based telemonitoring intervention on the number and length of hospital admissions. Methods A randomised controlled trial was carried out across 20 health centres in Bilbao (Basque Country, Spain) to assess the impact of home telemonitoring on in-home chronic patients compared with standard care. The study lasted for one year. Fifty-eight in-home patients, diagnosed with heart failure (HF) and/or chronic lung disease (CLD), aged 14 or above and with two or more hospital admissions in the previous year were recruited. The intervention consisted of daily patient self-measurements of respiratory-rate, heart-rate, blood pressure, oxygen saturation, weight, body temperature and the completion of a health status questionnaire using PDAs. Alerts were generated when pre-established thresholds were crossed. The control group (CG) received usual care. The primary outcome measure was the number of hospital admissions that occurred at 12?months post-randomisation. The impact of telemonitoring on the length of hospital stay, use of other healthcare resources and mortality was also explored. Results The intervention group (IG) included 28 patients and the CG 30. Patient baseline characteristics were similar in both groups. Of the 21 intervention patients followed-up for a year, 12 had some admissions (57.1%), compared to 19 of 22 controls (86.4%), being the difference statistically significant (p?=?0.033, RR 0.66; 95%CI 0.44 to 0.99). The mean hospital stay was overall 9?days (SD 4.3) in the IG versus 10.7 (SD 11.2) among controls, and for cause-specific admissions 9 (SD 4.5) vs. 11.2 (SD 11.8) days, both without statistical significance (p?=?0.891 and 0.927, respectively). Four patients need to be telemonitored for a year to prevent one admission (NNT). There were more telephone contacts in the IG than in the CG (22.6 -SD 16.1- vs. 8.6 -SD 7.2-, p?=?0.001), but fewer home nursing visits (15.3 -SD 11.6- vs. 25.4 -SD 26.3-, respectively), though the difference was not statistically significant (p?=?0.3603). Conclusions This study shows that telemonitoring of in-home patients with HF and/or CLD notably increases the percentage of patients with no hospital admissions and indicates a trend to reduce total and cause-specific hospitalisations and hospital stay. Home telemonitoring can constitute a beneficial alternative mode of healthcare provision for medically unstable elderly patients. Trial registration Current Controlled Trials ISRCTN89041993
机译:背景技术越来越多的证据表明,随着慢性病患病率的增加,家庭远程监控在社会中可能是有利的。这项研究的主要目的是评估基于初级保健的远程监控干预对住院人数和住院时间的影响。方法在毕尔巴鄂(西班牙巴斯克地区)的20个医疗中心进行了一项随机对照试验,以评估与标准护理相比,家庭远程监护对家庭慢性病患者的影响。该研究持续了一年。招募了五十八名在上一年中被诊断为心力衰竭(HF)和/或慢性肺部疾病(CLD),年龄在14岁或以上并有两次或多次入院的家庭患者。干预措施包括每天对患者的呼吸频率,心率,血压,血氧饱和度,体重,体温进行自我测量,并使用PDA完成健康状况调查表。超过预设的阈值时会生成警报。对照组(CG)接受常规护理。主要结局指标是随机化后12个月发生的住院人数。还探讨了远程监控对住院时间,使用其他医疗资源和死亡率的影响。结果干预组(IG)包括28例患者和CG 30例。两组患者的基线特征相似。在一年随访的21名干预患者中,有12名入院(57.1%),而22名对照组中有19名(86.4%),差异具有统计学意义(p?=?0.033,RR 0.66; 95%CI 0.44至0.99)。 IG的平均住院时间为9天(SD 4.3),对照组为10.7(SD 11.2),因病入院的平均住院时间为9(SD 4.5)对11.2(SD 11.8)天,两者均无统计学意义( p 1分别为0.891和0.927。每年需要对四名患者进行远程监护,以防止一次入院(NNT)。 IG中的电话联系多于CG(22.6 -SD 16.1- vs. 8.6 -SD 7.2-,p?=?0.001),但家庭护理就诊次数较少(15.3 -SD 11.6- vs. 25.4 -SD 26.3 -),尽管差异在统计上并不显着(p = 0.3603)。结论这项研究表明,对家庭中患有HF和/或CLD的患者进行远程监护显着增加了没有住院的患者的比例,并表明减少总住院人数和特定原因住院人数和住院时间的趋势。家庭远程监控可以为医疗不稳定的老年患者提供有益的替代医疗保健模式。试用注册电流对照试验ISRCTN89041993

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号